Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,793 | 792 | 88.0% |
| Consulting Fee | $1,865 | 1 | 11.9% |
| Education | $21.46 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,322 | 245 | $0 (2024) |
| PFIZER INC. | $2,288 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,066 | 126 | $0 (2024) |
| Gilead Sciences, Inc. | $1,435 | 73 | $0 (2024) |
| Janssen Biotech, Inc. | $1,318 | 83 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $745.60 | 37 | $0 (2024) |
| QOL Medical, LLC | $522.03 | 34 | $0 (2024) |
| Braintree Laboratories, Inc. | $236.40 | 14 | $0 (2022) |
| Concordia Pharmaceuticals Inc. | $197.81 | 10 | $0 (2019) |
| Ardelyx, Inc. | $191.15 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,124 | 113 | ABBVIE INC. ($859.73) |
| 2023 | $1,799 | 86 | ABBVIE INC. ($732.55) |
| 2022 | $2,325 | 120 | ABBVIE INC. ($758.62) |
| 2021 | $1,738 | 104 | AbbVie Inc. ($556.72) |
| 2020 | $1,173 | 74 | AbbVie Inc. ($375.83) |
| 2019 | $1,635 | 103 | AbbVie, Inc. ($368.26) |
| 2018 | $3,601 | 104 | PFIZER INC. ($2,012) |
| 2017 | $1,285 | 91 | AbbVie, Inc. ($318.28) |
All Payment Transactions
795 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/04/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 575 | 593 | $340,841 | $57,785 |
| 2022 | 17 | 616 | 637 | $348,210 | $61,031 |
| 2021 | 18 | 749 | 771 | $424,756 | $73,185 |
| 2020 | 19 | 707 | 753 | $345,838 | $67,509 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 84 | 84 | $98,868 | $14,450 | 14.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 48 | 48 | $41,760 | $7,898 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $16,483 | $5,924 | 35.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 72 | 72 | $54,576 | $5,409 | 9.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 24 | 24 | $20,880 | $4,016 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 58 | $7,946 | $3,499 | 44.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 33 | 33 | $34,353 | $3,165 | 9.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $6,575 | $2,152 | 32.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $15,660 | $1,939 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 21 | $4,242 | $1,828 | 43.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 24 | $3,312 | $1,413 | 42.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $12,407 | $1,390 | 11.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 28 | 32 | $2,400 | $1,102 | 45.9% |
| 43450 | Dilation of esophagus | Facility | 2023 | 33 | 33 | $13,002 | $963.87 | 7.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 15 | 15 | $2,895 | $918.30 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,424 | $900.90 | 37.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 22 | 22 | $3,058 | $817.27 | 26.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 71 | 71 | $83,567 | $12,183 | 14.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 78 | 78 | $24,258 | $8,349 | 34.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 42 | 42 | $36,540 | $6,946 | 19.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 76 | 78 | $59,124 | $5,466 | 9.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 47 | 47 | $48,927 | $5,460 | 11.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 27 | 27 | $23,490 | $4,532 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 70 | $9,590 | $4,326 | 45.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 32 | $8,416 | $3,012 | 35.8% |
About Dr. Brendan O'hare, M.D
Dr. Brendan O'hare, M.D is a Specialist healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669678116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brendan O'hare, M.D has received a total of $15,679 in payments from pharmaceutical and medical device companies, with $2,124 received in 2024. These payments were reported across 795 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($13,793).
As a Medicare-enrolled provider, O'hare has provided services to 2,647 Medicare beneficiaries, totaling 2,754 services with total Medicare billing of $259,509. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Murfreesboro, TN
- Active Since 06/22/2007
- Last Updated 11/15/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1669678116
Products in Payments
- XELJANZ (Drug) $2,209
- XIFAXAN (Drug) $1,812
- RINVOQ (Biological) $1,264
- STELARA (Biological) $722.56
- HUMIRA (Biological) $697.06
- Humira (Biological) $626.27
- CREON (Drug) $479.08
- SKYRIZI (Biological) $389.23
- REMICADE (Biological) $377.75
- MAVYRET (Drug) $368.39
- Sucraid (Drug) $343.96
- ENTYVIO (Biological) $297.52
- GATTEX (Drug) $264.36
- TREMFYA (Drug) $208.05
- Entyvio (Biological) $198.48
- IBSRELA (Drug) $191.15
- GIMOTI (Drug) $184.50
- Mavyret (Drug) $184.09
- LINZESS (Drug) $181.51
- SUCRAID (Drug) $178.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Murfreesboro
Dr. Paulino Goco, Md, MD
Specialist — Payments: $13,212
Tina Covington Gresham, M.d, M.D
Specialist — Payments: $6,646
Dr. Chad Jackson, M.d, M.D
Specialist — Payments: $6,399
Dr. Gregory Taylor, M.d, M.D
Specialist — Payments: $5,544
Dr. Colleen Bratsch, D.o. F.a.c.o.g, D.O. F.A.C.O.G
Specialist — Payments: $4,331
Dr. William Noah, Md, MD
Specialist — Payments: $4,301